We hypothesized that the measurement of cumulative IgE levels specific for respiratory allergens by PhadiatopTM testing may be useful for asthma phenotyping and in particular to identify patients with allergen-triggered asthma to choose IgE-targeted strategies for the 5th stage of therapy for severe asthma. Here, IGHE is linked to asthma.